CMPOne Day(%)Weekly(%)Monthly(%)Quarterly(%)Half Yearly(%)Year(%)YTD(%)52 Weeks High52 Weeks Low
1105.35 0.98 0.98 0.98 0.98 0.98 54.93 16.22 1098.50 848.20
* Not adjusted for Corporate Action i.e. Bonus / Split / Dividend
Report DateResearch houseDescriptionRecoAt PriceTarget PriceUpSide
/DownSide
Download
31-Jul-17 Isec Subdued Q1; biosimilars progress to hold key Hold 386 380 -1.55
28-Jul-17 Nirmal Bang Sec Revenues Below Expectations Sell 391 246 -37.08
14-Jul-17 Isec ODAC panel recommendation improves prospect of Trastuzumab appro.. Hold 400 375 -6.25
2-May-17 Nirmal Bang Sec Lower Licensing Income And Decline In Syngene Revenues Hurt Earni.. Sell 1104 739 -33.06
2-May-17 Isec Subdued Q4; biosimilars progress to hold key Hold 1100 1020 -7.27

Upcoming Events and Recent Updates

16-Aug-17
Post ITs (Interesting Article) - Biocon pulls application for EU approval of two drugs  ( updated on Aug 18 2017)
Download 17-Aug-17
Announcement - Analyst / Investor Meet – Intimation  ( updated on Aug 17 2017)
17-Aug-17
Post ITs (Interesting Article) - Biocon withdraws applications to sell two cancer drugs in Europe  ( updated on Aug 17 2017)
16-Aug-17
Post ITs (Interesting Article) - Biocon seeks withdrawal of application for two biosimilars under European drug regulator review  ( updated on Aug 16 2017)
16-Aug-17
Post ITs (Interesting Article) - Biocon withdraws EMA dossiers for Trastuzumab, Pegfilgrastim  ( updated on Aug 16 2017)
16-Aug-17 Biocon added this week in RB Model portfolio by Orunda
16-Aug-17 Do Read Action Rationale of Biocon by Orunda
Nominated for the RB Investor Communication Awards 2015

Analyst Calls / Meets


Management Interviews

12-Jun-17 Kiran Muzumdar ..  
28-Apr-17 Kiran Mazumdar ..  
24-Mar-17 Kiran Mazumdar ..  
15-Mar-17 Kiran Mazumdar ..  
03-Mar-17 Kiran Mazumdar ..  

Investor Presentations

30-Jun-17 Investor/Anal...
28-Apr-17 Investor/Anal...
01-Feb-17 Investor/Anal...
30-Nov-16 Investor/Anal...
30-Jun-16 Investor/Anal...

Annual Reports
Source: Reportjunction.com

2016-17  
2015-16  
2014-15  
2013-14  
2012-13  

Research Showcase

31-Jul-17
Isec - Quarter ..
Download
28-Jul-17
Nirmal Bang Sec..
Download
14-Jul-17
Isec - Company ..
Download
02-May-17
Nirmal Bang Sec..
Download
02-May-17
Isec - Quarter ..
Download

Results

27-Jul-17 Results
27-Apr-17 Results
24-Jan-17 Results
20-Oct-16 Results
21-Jul-16 Results

AGM/EGM/Board Meetings

28-Jul-17 - AGM
27-Jul-17 - Quarterly Results
07-Jun-17 - POM
27-Apr-17 - Others
24-Jan-17 - Quarterly Results

Company Announcements


RB Model Portfolio

16-Aug-17 Orunda bought 267101  Shares RB Model Portfolio
26-Jul-17 MV71380 sold -238091  Shares RB Model Portfolio
21-Jul-17 MV71380 sold -234797  Shares RB Model Portfolio
17-Jul-17 MV71380 bought 25000  Shares RB Model Portfolio
15-Jul-17 MV71380 sold 0  Shares RB Model Portfolio

Press Release

13-Jul-17 Press Release
05-May-17 Press Release
07-Feb-17 Press Release
24-Jan-17 Press Release
21-Jul-16 Press Release

 

Credit Ratings

12-Jan-17 Short-Term Rating ICRA A1+ Reaffirmed
12-Jan-17 Long-Term Rating [ICRA]AA+ (Stable) Reaffirmed
11-Aug-16 Short-Term Rating CRISIL A1+ Reaffirmed
11-Aug-16 Long-Term Rating CRISIL AA+/Stable Reaffirmed
08-Sep-15 Short-Term Rating ICRA A1+ Reaffirmed

Archived Documents

No Archieved Transcript.